Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis at preliminary diagnosis

Cheng-tao WANG,Ka-jia CAO,Guo-feng XIE,Ying-ying ZHANG,Pei-yu HUANG
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2009.06.018
2009-01-01
Abstract:OBJECTIVE: To investigate prognostic factors for patients with M1 stage NPC. METHODS: From January 1997 to December 2003, 209 patients with NPC and distant metastasis during diagnosis and treatment were treated, and the survival rate was calculated and compared with Kaplan-Meier method and Logrank test. A multivariate analysis was performed with Cox model. RESULTS: The 1, 2, 3-year survival rates were 61.0%, 32.0%, 16.0% respectively, with median survival time of 15.47 months (range, 0.83-96.63). In 27 patients who were not treated the 1, 2, 3-year survival rates were 37.0%, 14.0% and 5.0%, and the median survival time was 9.23 months (2.80-44.23). In 182 patients who were treated, the medion survival time was 17.6 months (0.83-96.63), and the 1, 2, 3-year survival rates were 65.0%, 35.0% and 18.0% (χ2 = 11.642, P = 0.001). The univariate analysis showed that sex (P = 0.038), the therapy modality (P = 0.000) and numbers of chemotherapy cycle (P = 0.000) were the prognostic factors of the patients. The multivariate analysis showed that the therapy modality (P = 0.004) and numbers of chemotherapy cycle (P = 0.001) were the independently prognostic factors. CONCLUSION: The therapy modality and numbers of chemotherapy cycle were the independently prognostic factors for the NPC patients with distant metastasis at preliminary diagnosis.
What problem does this paper attempt to address?